Objective: in this study, we aimed to measure changes in red blood cell (RBC) 
Introduction
Infection is a serious complication of total hip arthroplasty. The rate of infection is 0.3-2.2%, despite attempts to prevent it [1, 2] . The immune system plays a critical role in preventing infection, and red blood cells (RBCs) are an important part of the immune response [3] [4] [5] . However, it is not known whether total hip joint replacement affects the RBC immune function.
Nelson [6] found that RBCs displayed immune adhesion against pneumococcus and that RBCs could enhance macrophage phagocytosis of bacteria. A number of studies [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] have shown that the adhesion of RBC was accomplished by glycoproteins CR1 (or CD35) located in the membrane. RBCs could form rosettes with invasive pathogens, including tumor cells and bacteria, and reduced pathogens in target organs; pathogens were eliminated after RBC adhesion due to a change in surface charge. RBCs present pathogens to phagocytes and promote their removal by macrophages as they adhere to them and pass through the liver and spleen; then RBCs reenter the circulation. After RBCs adhere to pathogens, peroxidases are concentrated at CR1 on the cell membrane and directly destroy adhesive antigens; in this way RBCs act as agents of cell-mediated immunity. After adhesion RBCs also produce cytokines or special marker molecules and thereby regulate the immune response [12, 17, 18] .
Co-culture of RBCs and peripheral blood lymphocytes was shown to promote amplification of lymphocytes [19] [20] [21] [22] , maintain lymphocyte activity and reduce apoptosis of lymphocytes. CD58 and CD59 on the RBC membrane are the natural ligands of lymphocyte receptor CD2 when the cells come into contact. CD58 interacts with CD2 on the lymphocyte membrane to induce production of cytokines by T lymphocytes, and indirectly promotes the proliferation and differentiation of B lymphocytes [23] [24] [25] . RBCs may induce B lymphocytes to enter mitosis from the resting stage, and promote their proliferation and differentiation to produce antibodies. The expression of CD35, CD58 and CD59 on the RBC surface could be used as indicators of the immune function. RBCs interacting with other immune cells may form a complex network of immune regulation and so act as indispensable components of the immune system.
In this study, we hypothesized that RBCs' natural tumor RBC rosette (NTERR), I-type complement receptor rosette rate (RC3bRR) may decrease after a total hip replacement compared with pre-surgery. The expression of CD35, CD58 and CD59 on the RBC membrane and the promotion of lymphocyte proliferation rates by RBCs might also decline after surgery. Tumor necrosis factor α (TNF-α), interleukin 2 (IL-2), interferon γ (IFN-γ), interleukin 10 (IL-10) and prostaglandin E 2 (PGE 2 )] concentrations in RBC and lymphocyte culture fluid could also change post-operation. Such modification of RBC immune function may be involved in the occurrence and development of infection after total hip arthroplasty.
Material and methods

Patients
Twenty patients undergoing total hip joint replacement were selected from those presenting with femoral neck fractures at the Second People's Hospital of Anhui Province between October 2010 and October 2011, including 9 males and 11 females, aged 62 to 75 years old (average 67.7 yrs). No patients had serious cardiovascular disease, diabetes, or other non-associated injuries. No abnormalities were found during routine preoperative examination. No steroids or other drugs affecting the immune system were used during 3 months before the study. In addition, 20 healthy individuals were also selected as the control group, aged 65 to 70 years old (average 68.2 yrs). There was no significant difference in age or gender between the two groups ( Table 1) . Patients were treated with epidural anesthesia, and the total hip joint replacement was done using a hip posterior approach. The joint products were from Montagne Company. The models were JX/W-HA with biological types. No blood transfusion was applied during the surgery. The average operative time was 75.6 minutes, performed by the same group of doctors. Patients' peripheral blood was drawn one day before the surgery and one day after surgery.
Reagents and instruments
Reagents included Ehrlich ascites cancer cells (frozen) and zymosan (frozen) provided by the Department of Immunology of the Second Military Medical University, Shanghai Changhai Hospital. Lymphocyte separation medium was purchased from Shanghai Hua-Jing Biological Technology Co., Ltd. Lymphocyte culture medium 1640 was purchased from Beijing Solarbio. Lipopolysaccharide (LPS) was from Sigma Company. Phytohemagglutinin (PHA) was from Guangzhou Biomedical Engineering. TNF-α, IL-2, IFN-γ, IL-10, and PGE 2 kits were purchased from Shanghai Yingxin Laboratory Equipment Co., Ltd. CD35, CD58, and CD59 reagents were from IMMUNOTECH. The main instruments included flow cytometry (Beckman Coulter Model, Epics XL); RA-XT automatic biochemical analyzer; CO 2 incubator (HF 212UV, Shanghai Li-shen Scientific Instrument Co., Ltd); low speed self-balancing centrifuge (LDZ-2 type, Beijing Medical Centrifuge Co., Ltd); and electric heated water bath (Grant Y14 type, Grant Instrument Ltd). 2. RBC C3b detection 1) Aspirated, anticoagulant-treated fresh blood (1 ml) was centrifuged and the supernatant removed, RBCs were washed with saline and centrifuged three times, 2000 r/ min, 3 ~ 5 min, and suspended at 1.25 × 10 7 /ml. 2) Zymosan reagent was fully dispersed by pipetting in a 37 o C water bath to l × 10 8 /ml. 3) 50 μl of zymosan were added to 50 μl of serum in a test tube, then 50 μl of RBC suspension was added and mixed well, placed in a 37 o C water bath for 30 min, removed and 25 μl of 0.25% glutaraldehyde was added and mixed gently, smeared, and blown dry for Giemsa staining. Under high magnification, RBCs were purple color and yeast was blue; both were counted. Two or more yeast adhered to an RBC was identified as a garland. Two hundred RBCs were counted, and the percentage of positive cells in garlands were counted.
RBC
RBC promotion of lymphocyte proliferation 1 . Preparation for lymphocyte suspension: 1 ml of sterile anticoagulant-treated blood was diluted with 1 ml of 
Cytokine detection
TNF-α, IL-2, IFN-γ, IL-10 and PGE 2 kits (Shanghai Ying-xin Laboratory Equipment Co) were used in accordance with the manufacturer's instructions to test supernatants removed from cell culture in the experimental groups.
RBC membrane CD35, CD58 and CD59 expression by flow cytometry
Anticoagulated whole blood was centrifuged at 1000 r/ min for 3 min to enrich for RBCs. We took three 12 × 75 mm test tubes, aspirated RBCs of 1 μl from the bottom of the tube, added 5 μl of antibodies, shook and mixed cells and antibodies well; then incubated at room temperature for 10 min and avoided light. We suspended cells in 500 μl of PBS for flow cytometry, measuring positive percentage and mean fluorescence intensity of CD35, CD58 and CD59 on the RBC surface.
Statistical analysis
Data were expressed as mean ± standard deviation (X ± SD). An independent sample t-test was used to compare 
Tnf-α -tumor necrosis factor α; IL-2 -interleukin 2; INF-γ -interferon γ; IL-10 -interleukin 10; PGE 2 -prostaglandin E 2
each index between the control group and the 1 day pre-surgery group; or the t' test was used. Each indicator in the 1 day postsurgical group and the 1 day presurgical was compared using a paired t test. We used SPSS11.0 software for statistical analysis, with a significance cutoff at p = 0.05.
Results
Indices in presurgical group and healthy adult group
Each index in the one day presurgical group for 20 patients was not significantly different compared with the healthy adult control group (n = 20) as shown in Table 1 .
Postoperative RBC natural tumor erythrocyte rosette rate (NTERR) and RBC C3b receptor rosette rate (RC3bRR)
The postoperative natural tumor cell rosette rate was significantly lower than 1 day before surgery (t = 3.05, p < 0.01) as shown in Fig. 1 . The postoperative I type complement receptor rosette rate was also significantly lower than one day before surgery (t = 4.28, p < 0.001), as shown in Fig. 1. 
RBC promotion of the lymphocyte proliferation rate
RBC promotion of the T lymphocyte proliferation rate was significantly lower at one day after surgery than one day before surgery (t = 4.28, p < 0.001) as shown in Fig. 2; RBC   Fig. 1 . Postoperative I type complement receptor rosette rate and natural tumor cell rosette rate at one day after surgery were significantly lower than one day before surgery (t = 4.28, p < 0.001; t = 3.05, p < 0.01) promotion of the B lymphocyte proliferation rate was also significantly lower at one day after surgery than one day before surgery (t = 4.28, p < 0.001), as also shown in Fig. 2 .
Cytokine levels and RBC membrane CD35, CD58 and CD59 expression
The concentrations of TNF-α, IL-2 and IFN-γ in RBC and lymphocyte culture fluids were significantly decreased after surgery (p < 0.001). However, the concentrations of IL-10 and PGE 2 increased significantly after surgery (p < 0.001) as shown in Fig. 3 . Expressions of CD35, CD58 and CD59 were significantly lower after surgery than before (p < 0.001) as shown in Fig. 4 and Fig. 6 . The fluorescence intensities of CD35, CD58 and CD59 after surgery were also significantly lower than before surgery (p < 0.05) as shown in Fig. 5 . 
Discussion
RBCs account for about 50% of whole blood volume derived from bone marrow pluripotent stem cells. RBCs are the main cellular component of blood. In the past, people thought that RBCs had a simple structure and a single function, serving to transport O 2 and CO 2 . Siegel et al. [26] presented the concept of the RBC immune system in 1981. Since then, innate immune molecules related to RBCs have been constantly being discovered [27] . Innate immune molecules on RBCs include CD35, CD58, CD59, CD44, CD55, CR3, NKEF, ECKR, PIE and the SOD enzyme. These immune molecules have a variety of complex innate immune functions and regulate other immune responses. RBCs function to recognize, adhere, remove antigens and clear IC. In addition, RBCs participate in many immune responses and in immune regulation using a complete self-regulatory system. RBC immunity is an important part of the body's immune system. RBC immunology has received a great deal of attention from researchers recently.
More and more studies have confirmed that changes in the innate immune functions of RBCs are closely related to disease occurrence and development [3, 4] . For instance, a natural RBC immune deficiency was reported to play an important role in the pathogenesis of the autoimmune disease SLE [28] ; RBC immune function declined in cancer patients [29] ; and abnormal redox reactions in RBCs affected the integrity and function of T lymphocytes, promoting atherosclerosis in carotid arteries [30] . Golenkina et al. [31] found that RBCs interfered in the synthesis of leukotriene by polymorphonuclear leukocytes exposed to salmonella, and presumed that it played a role by regulating intracellular and extracellular NO exchange and metabolism. Jack et al. [32] proved that RBCs were the core cells of nitrosation in acute inflammation and could trigger uncontrolled blood vessel dilation. They proposed that RBCs directly mediate hypotension through a NO dependent mechanism, and used this theory to explain abnormal blood flow response in sepsis. Beck et al. found that RBCs could adhere to HIV-1 and might be involved in the infection of target cells by the virus [13] . However, to date it has not been reported that major surgery can affect RBC immune function.
In this study, we observed that the RBC rosette rate was significantly lower one day after surgery in patients who had total hip replacement than one day before surgery, or than in healthy controls. RBC promotion of T and B lymphocyte proliferation rates also were significantly decreased (p < 0.05). Immune-enhancing cytokines such as TNF-α, IL-2 and IFN-γ in the culture medium after RBCs were co-cultured with lymphocytes decreased, whereas the immunosuppressive factors IL-10 and PGE 2 increased, which further certified that the immune promoting function of RBCs was reduced. The expression of CD35, CD58 and CD59 on the RBC membrane decreased after surgery compared with before surgery (p < 0.05). This could account for the decreases we observed in RBC immune rosette formation and in RBC promotion of lymphocyte proliferation.
Due to leg buckling, dislocation, traction, retractor oppression, prosthesis oppression, etc. for a long time, total hip replacement can cause entire or partial lower limb ischemia, especially severe ischemia in the muscles around the joint. Surgery can also cause an increase in circulating immune complexes and activation of complement and phagocytes, which can lead to massive release of oxygen free radicals and damage to RBCs [33, 34] . RBC membrane peroxidation increased after total hip replacement. These injuries changed the enzyme activity so that the RBC membrane immune receptor was inactivated. This could explain why we observed in this study that the expression of RBC membrane proteins CD35, CD58 and CD59 decreased after surgery compared to levels prior to surgery and in healthy controls. We observed that total hip replacement caused a decrease in RBC immune function, which might affect the occurrence and development of infection after surgery. This study provides a new way to address the problem of infection after total hip replacement.
Our study still had some limitations: the sample size was not large enough and we did not measure dynamic changes in RBC immunity. Further research needs to be conducted in order to improve RBC immune function in infected patients after total hip replacement by therapeutic intervention.
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